CBNLCF
PFE icon

Cognios Beta Neutral Large Cap Fund’s Pfizer PFE Stock Holding History

Cognios Beta Neutral Large Cap Fund’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,066
Closed -$520K – 105
2023
Q4 		$520K Buy
18,066
+739
+4% +$22.3K 0.68% 68
2023
Q3 		$575K Sell
17,327
-317
-2% -$11.2K 0.74% 56
2023
Q2 		$647K Sell
17,644
-4,649
-21% -$181K 0.75% 68
2023
Q1 		$901K Buy
22,293
+1,523
+7% +$65.8K 0.86% 56
2022
Q4 		$1.06M Buy
+20,770
New +$996K 1.02% 25
2018
Q2 		$934K Buy
+27,155
New +$928K 0.33% 118

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Cognios Beta Neutral Large Cap Fund's PFE Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund sold out of Pfizer (PFE) in Q1 2024, closing a stake of 18,066 shares — an estimated $520K sold.

Cognios Beta Neutral Large Cap Fund first reported a position in PFE in Q2 2018 and held it in 6 quarters. The position peaked at $1.06M in Q4 2022. 2,884 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Cognios Beta Neutral Large Cap Fund reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Cognios Beta Neutral Large Cap Fund sold 18,066 Pfizer shares in Q1 2024, an estimated $520K.
  • Cognios Beta Neutral Large Cap Fund first reported a position in Pfizer in Q2 2018 and held it in 6 quarters.
  • Cognios Beta Neutral Large Cap Fund's Pfizer position peaked at $1.06M in Q4 2022.
  • 2,884 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.